JPMorgan Chase & Co. reaffirmed their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note published on Wednesday,Digital Look reports. Other analysts have also recently issued research reports about the company. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 2,100 price target on shares of GSK in […]

JPMorgan Chase & Co. reissued their overweight rating on shares of Relx (LON:REL – Free Report) in a research report released on Wednesday morning,Digital Look reports. REL has been the topic of a number of other reports. Royal Bank Of Canada reissued an “overweight” rating on shares of Relx in a research note on Tuesday, […]

JPMorgan Chase & Co. reissued their overweight rating on shares of Fresnillo (LON:FRES – Free Report) in a research report released on Monday morning,London Stock Exchange reports. They currently have a GBX 4,300 price objective on the stock. A number of other research analysts have also weighed in on FRES. Canaccord Genuity Group raised their […]

AstraZeneca (LON:AZN – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Tuesday,Digital Look reports. Several other research analysts also recently commented on the stock. Shore Capital reissued a “buy” rating and set a £145 price objective […]

JPMorgan Chase & Co. reiterated their overweight rating on shares of AstraZeneca (LON:AZN – Free Report) in a research note published on Tuesday morning,Digital Look reports. Several other brokerages also recently issued reports on AZN. Jefferies Financial Group reiterated a “buy” rating and issued a £150 price target on shares of AstraZeneca in a report […]